OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests
KKR's HealthCare Royalty (HCRx) expanded its strategic relationship with OPKO Health by purchasing $125 million in senior secured notes backed by OPKO's Mazdutide royalty interests. The notes mature in 2044 and feature a payment cap at 1.5 times the funded amount, after which OPKO retains the remaining royalty economics from the franchise.
Key figures
- Deal Value Usd
- 125000000
- Maturity year
- 2044
- Payment cap multiple
- 1.5
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.